Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Closes $5.2M Offering

Premium

Tekmira Pharmaceuticals said this week that it has closed a previously announced public offering of more than 1.7 million units of stock and warrants, grossing the company C$5.1 million ($5.2 million).

Each unit consists of one share of common stock and a half a warrant to purchase one common share, the company said.

Proceeds of the offering will be used for general corporate purposes, Tekmira said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.